Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 3 mg/mL Gablofen Intrathecal Injection
NCT01520545Phase 3Completed
- Sponsor
- Piramal
- Start
- Dec 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen in spasticity, sponsored by Piramal. Started Dec 2012; status: completed.
02
Drugs
baclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01520545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520545.